Welcome to our dedicated page for Ge Healthcare Technologies news (Ticker: GEHC), a resource for investors and traders seeking the latest updates and insights on Ge Healthcare Technologies stock.
GE Healthcare Technologies Inc (GEHC) delivers innovative medical technologies that shape global healthcare through advanced imaging, diagnostics, and patient care solutions. This page provides direct access to official company announcements, financial disclosures, and strategic developments.
Investors and industry professionals will find a centralized repository of GEHC news, including earnings reports, product launches, regulatory updates, and partnership announcements. All content is sourced from verified channels to ensure accuracy and timeliness.
Regular updates cover GEHC's advancements in medical imaging systems, AI-driven diagnostics, and healthcare digitization trends. Bookmark this page to monitor the company’s progress in addressing complex clinical challenges while maintaining compliance with global regulatory standards.
GE HealthCare reported first-quarter 2024 financial results with a 1% decline in revenues year-over-year. The net income margin increased to 8.0%, and adjusted EBIT margin was 14.7%. Diluted EPS rose to $0.81, with adjusted EPS at $0.90. Cash flow from operating activities was $419 million, with free cash flow at $274 million. The company repaid $150 million of debt in January 2024. GE HealthCare reaffirmed its full-year 2024 guidance.
GE HealthCare received FDA clearance for its Portrait VSM vital signs monitor, enhancing its connected patient monitoring solutions. The device offers precise readings for blood pressure, pulse rate, oxygen saturation, body temperature, and respiratory rate. It utilizes SuperSTAT non-invasive blood pressure algorithm and wireless connectivity for seamless EMR integration. The Portrait VSM integrates with Portrait Mobile for continuous patient monitoring, streamlining clinical workflows and enabling timely intervention to prevent patient deterioration.